Zadnji put ažurirano :
16/01/2021
Infostab
Liste
Liste sazetaka
Potražite inkompatibilnosti
Tablica inkompatibilnosti
Bibliografija
Istraživačkih timova
Plakat
Linkovi
Autor
Priručnik za korisnike
Bilten
Bibliografija 4433
Vrsta :
Časopis
Weblink :
https://doi.org/10.1016/j.clinthera.2020.01.017
Istraživačkih timova :
Philadelphie - Philadelphia College of Pharmacy and Science
Autor :
Ghazi I.M, El Nekidy W.S, Sood A, Dulku A, Patel R, Patel K.
Naslov :
Y-site Administration of Imipenem/Cilastatin/ Relebactam With Common Intravenous Medications
Référence :
Clin Ther ; 42, 3: 475-485. 2020
Razina dokaza :
Fizička stabilnost :
Kemijska stabilnost :
Ostale metode :
Komentari :
Liste
Dexamethasone sodium phosphate
1 mg/ml
+
Imipenem-Cilastatin / Relebactam
5 mg/ml
+
Furosemide
10 mg/ml
+
Imipenem-Cilastatin / Relebactam
5 mg/ml
+
Haloperidol
5 mg
+
Imipenem-Cilastatin / Relebactam
5 mg/ml
+
Hydrocortisone sodium succinate
1 mg/ml
+
Imipenem-Cilastatin / Relebactam
5 mg/ml
+
Imipenem-Cilastatin / Relebactam
5 mg/ml
+
Dexamethasone sodium phosphate
1 mg/ml
+
5 mg/ml
+
Furosemide
10 mg/ml
+
5 mg/ml
+
Haloperidol
5 mg
+
5 mg/ml
+
Hydrocortisone sodium succinate
1 mg/ml
+
5 mg/ml
+
Insulin glulisine
1 U/ml
+
5 mg/ml
+
Labetalol hydrochloride
2 mg/ml
+
5 mg/ml
+
Phenytoin sodium
5 mg/ml
+
Insulin glulisine
1 U/ml
+
Imipenem-Cilastatin / Relebactam
5 mg/ml
+
Labetalol hydrochloride
2 mg/ml
+
Imipenem-Cilastatin / Relebactam
5 mg/ml
+
Phenytoin sodium
5 mg/ml
+
Imipenem-Cilastatin / Relebactam
5 mg/ml
+
Mentions Légales